These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20825416)

  • 1. Global histone acetylation levels: prognostic relevance in patients with renal cell carcinoma.
    Mosashvilli D; Kahl P; Mertens C; Holzapfel S; Rogenhofer S; Hauser S; Büttner R; Von Ruecker A; Müller SC; Ellinger J
    Cancer Sci; 2010 Dec; 101(12):2664-9. PubMed ID: 20825416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma.
    Ellinger J; Kahl P; Mertens C; Rogenhofer S; Hauser S; Hartmann W; Bastian PJ; Büttner R; Müller SC; von Ruecker A
    Int J Cancer; 2010 Nov; 127(10):2360-6. PubMed ID: 20162570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma.
    Rogenhofer S; Kahl P; Mertens C; Hauser S; Hartmann W; Büttner R; Müller SC; von Ruecker A; Ellinger J
    BJU Int; 2012 Feb; 109(3):459-65. PubMed ID: 21810159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do DNA-methylation and histone acetylation play a role in clear cell renal carcinoma? Analysis of radical nephrectomy specimens in a long-term follow-up.
    Minardi D; Lucarini G; Filosa A; Zizzi A; Milanese G; Polito M; Polito M; Di Primio R; Montironi R; Muzzonigro G
    Int J Immunopathol Pharmacol; 2011; 24(1):149-58. PubMed ID: 21496397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Global Histone Acetylation Levels in Bladder Cancer Patients.
    Ellinger J; Schneider AC; Bachmann A; Kristiansen G; Müller SC; Rogenhofer S
    Anticancer Res; 2016 Aug; 36(8):3961-4. PubMed ID: 27466500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of global levels of histone modifications with recurrence-free survival in stage IIB and III esophageal squamous cell carcinomas.
    I H; Ko E; Kim Y; Cho EY; Han J; Park J; Kim K; Kim DH; Shim YM
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):566-73. PubMed ID: 20142251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased levels of histone H3K9me1 indicate poor prognosis in patients with renal cell carcinoma.
    Rogenhofer S; Kahl P; Holzapfel S; VON Ruecker A; Mueller SC; Ellinger J
    Anticancer Res; 2012 Mar; 32(3):879-86. PubMed ID: 22399607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of global DNA-methylation and histone acetylation in pT1a clear cell renal carcinoma in partial nephrectomy specimens.
    Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Primio RD; Montironi R; Muzzonigro G
    J Cell Mol Med; 2009 Aug; 13(8B):2115-2121. PubMed ID: 18752633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone H3 Lysine 4 Trimethylation, Lysine 27 Trimethylation, and Lysine 27 Acetylation Contribute to the Transcriptional Repression of Solute Carrier Family 47 Member 2 in Renal Cell Carcinoma.
    Yu Q; Liu Y; Zheng X; Zhu Q; Shen Z; Wang H; He H; Lin N; Jiang H; Yu L; Zeng S
    Drug Metab Dispos; 2017 Jan; 45(1):109-117. PubMed ID: 27821436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of
    Zhu Q; Yu L; Qin Z; Chen L; Hu H; Zheng X; Zeng S
    Epigenetics; 2019 Aug; 14(8):791-803. PubMed ID: 31088315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated histone H3 acetylation and loss of the Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell carcinoma.
    Banerjee A; Mahata B; Dhir A; Mandal TK; Biswas K
    J Biol Chem; 2019 Jan; 294(3):1005-1018. PubMed ID: 30463940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus.
    Tzao C; Tung HJ; Jin JS; Sun GH; Hsu HS; Chen BH; Yu CP; Lee SC
    Mod Pathol; 2009 Feb; 22(2):252-60. PubMed ID: 18953329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone modifications: implications in renal cell carcinoma.
    Ramakrishnan S; Ellis L; Pili R
    Epigenomics; 2013 Aug; 5(4):453-62. PubMed ID: 23895657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of centromere protein H is associated with progression of renal cell carcinoma.
    Wu X; Lin Y; Shi L; Huang Y; Lai C; Wang Y; Zhang M; Wang S; Heng B; Yu G; Du X; Fang L; Fu Y; Chen J; Guo Z; Su Z; Wu S
    J Mol Histol; 2015 Oct; 46(4-5):377-85. PubMed ID: 26248586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma.
    Park YS; Jin MY; Kim YJ; Yook JH; Kim BS; Jang SJ
    Ann Surg Oncol; 2008 Jul; 15(7):1968-76. PubMed ID: 18470569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global levels of histone modifications predict prognosis in different cancers.
    Seligson DB; Horvath S; McBrian MA; Mah V; Yu H; Tze S; Wang Q; Chia D; Goodglick L; Kurdistani SK
    Am J Pathol; 2009 May; 174(5):1619-28. PubMed ID: 19349354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
    Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of histone H3 serine 10 phosphorylation and histone H4 lysine 12 acetylation in oral squamous cell carcinoma.
    Campos-Fernández E; Matsuo FS; Andrade MF; Servato JPS; Loyola AM; Cardoso SV; Siva SJ; Moraes ADS; de Faria PR
    Histopathology; 2019 Jan; 74(2):227-238. PubMed ID: 30007038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
    Nofech-Mozes R; Khella HW; Scorilas A; Youssef L; Krylov SN; Lianidou E; Sidiropoulos KG; Gabril M; Evans A; Yousef GM
    Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.